Improvement effect of curcumin combined with fecal bacteria transplantation on mice with ulcerative colities induced by DSS

Yang LIU,Ming LU,Wen HONG,Kelin HUANG

PDF(763 KB)
PDF(763 KB)
J Jilin Univ Med Ed ›› 2024, Vol. 50 ›› Issue (1) : 136-142. DOI: 10.13481/j.1671-587X.20240117
Research in basic medicine

Improvement effect of curcumin combined with fecal bacteria transplantation on mice with ulcerative colities induced by DSS

  • Yang LIU,Ming LU(),Wen HONG,Kelin HUANG
Author information +
History +

Abstract

Objective To discuss the improvement effect of curcumin combined with fecal bacteria transplantation on the mice with dextran sulfate sodium (DSS)-induced ulcerative colitis (UC),and to clarify the related mechanism. Methods Fifty mice were randomly divided into control, model, curcumin, fecal bacteria transplantation, and combination groups. Except for the mice in control group (given distilled water),the mice in the other groups were given distilled water containing 2% DSS to establish the UC models. The mice in curcumin group were gavaged with 0.4 mL of 60 mg·kg-1 curcumin solution once per day for 10 d; the mice in fecal bacteria transplantation group underwent enema with 0.2 mL of fecal bacteria suspension once per day for 10 d; the mice in combination group received the enema of 0.2 mL fecal bacteria suspension and gavaged with 0.4 mL of 60 mg·kg-1 curcumin solution. At the end of the experiment, the disease activity index (DAI) and colon macroscopic damage index (CDMI) of the mice in various groups were calculated; the morphology of colon tissue of the mice in various groups was detected by HE staining;the levels of interleukin (IL)-1β, tumor necrosis factor-α(TNF-α), IL-4, and IL-10 in colon tissue of the mice in various groups were detected by enzyme-linked immunosorbent assay (ELISA) method;the expression levels of occludin and zonula occludens-1 (ZO-1) mRNA and proteins in colon tissue of the mice in various groups were detected by real-time fluorescence quantitative(RT-qPCR) and Western blotting methods. Results The intestinal mucosal epithelial structure of the mice in control group was intact and continuous with regular glandular arrangement and without inflammatory cell infiltration or ulceration; the intestinal mucosal epithelial structure of the mice in model group exhibited loss of colonic mucosal epithelium, disordered glandular arrangement, reduced goblet cells, congestion and edema in mucosal and submucosal layers, and extensive infiltration of inflammatory cells with widespread small ulcers; the intestinal mucosal epithelial structure of the mice in curcumin, fecal bacteria transplantation, and combination groups exhibited relatively intact colonic mucosal epithelial structures with reduced inflammatory cell infiltration and ameliorated mucosal and submucosal congestion and edema. Compared with control group, the DAI and CDMI of the mice in model group were increased (P<0.05), the levels of IL-1β and TNF-α were increased (P<0.05), the levels of IL-4 and IL-10 were decreased (P<0.05),and the expression levels of occludin and ZO-1 mRNA and proteins were decreased (P<0.05);compared with model group, the DAI and CDMI of the mice in curcumin, fecal bacteria transplantation, and combination groups were decreased (P<0.05),the levels of IL-1β and TNF-α were decreased (P<0.05), the levels of IL-4 and IL-10 were increased (P<0.05), and the expression levels of occludin and ZO-1 mRNA and proteins were increased (P<0.05). Compared with curcumin group and fecal bacteria transplantation group,the DAI and CDMI of the mice in combination group were decreased (P<0.05),the levels of IL-1β and TNF-α were decreased (P<0.05), the levels of IL-4 and IL-10 were increased (P<0.05), and the expression levels of occludin and ZO-1 mRNA and proteins were increased (P<0.05). Conclusion Curcumin combined with fecal bacteria transplantation can ameliorate the pathological damage in colonic tissue of the UC mice, inhibit the secretion of inflammatory factors, and promote the repaiment of intestin mucosa.

Key words

Ulcerative colitis / Inflammatory factor / Curcumin / Fecal bacteria transplantation / Dextran sulphate sodium

CLC number

R285.5

Cite this article

Download Citations
Yang LIU,Ming LU,Wen HONG,Kelin HUANG. Improvement effect of curcumin combined with fecal bacteria transplantation on mice with ulcerative colities induced by DSS. Journal of Jilin University(Medicine Edition). 2024, 50(1): 136-142 https://doi.org/10.13481/j.1671-587X.20240117

References

1 SHARARA A I, AWADHI S A, ALHARBI O, et al. Epidemiology, disease burden, and treatment challenges of ulcerative colitis in Africa and the Middle East[J]. Expert Rev Gastroenterol Hepatol,2018,12(9):883-897.
2 杨 坤, 孟 捷, 高 霞, 等. 姜黄素联合阿托伐他汀对溃疡性结肠炎小鼠的保护作用及机制研究[J]. 世界中医药, 2022, 17(2): 182-186.
3 朱立伟, 朱达坚. 姜黄素联合美沙拉嗪治疗轻中度溃疡性结肠炎的临床观察[J]. 广东医学, 2019, 40(20): 2921-2924.
4 林艺娟, 丁 健, 黄循铷, 等. 粪菌移植对小鼠实验性结肠炎TLR4信号通路及肠黏膜屏障的影响[J]. 中国微生态学杂志, 2021, 33(3): 256-263, 270.
5 翁剑锋, 徐 佳, 刘 朋, 等. 粪菌移植干预治疗溃疡性结肠炎的免疫学机制研究[J]. 中国全科医学, 2022, 25(3): 298-304.
6 代文洁, 张静阳, 曹平安. 粪菌移植对DSS诱导的实验性结肠炎小鼠影响[J]. 中国保健营养, 2019, 29(1):7-8.
7 李亚兰, 刘佳静, 马沛广, 等. 葛根芩连汤调控MMP-9/p38 MARK途径修复溃疡性结肠炎小鼠肠黏膜上皮屏障功能[J]. 中国实验方剂学杂志, 2021, 27(4): 8-15.
8 徐 磊, 沈 雁, 钟继红, 等. 姜黄素对溃疡性结肠炎小鼠Th17细胞分化相关因子表达水平的影响[J]. 中国现代应用药学, 2020, 37(1): 14-18.
9 DU L, HA C. Epidemiology and pathogenesis of ulcerative colitis[J]. Gastroenterol Clin North Am, 2020, 49(4): 643-654.
10 YAN Y X, SHAO M J, QI Q, et al. Artemisinin analogue SM934 ameliorates DSS-induced mouse ulcerative colitis via suppressing neutrophils and macrophages[J]. Acta Pharmacol Sin, 2018, 39(10): 1633-1644.
11 夏翩翩,邓飞鸿. YAP蛋白通过激活STAT3调控肠上皮细胞增殖在DSS诱导肠炎及相关肠癌中的作用[J]. 中南大学学报(医学版), 2022,47(12): 1637-1645.
12 SADEGHI N, MANSOORI A, SHAYESTEH A,et al. The effect of curcumin supplementation on clinical outcomes and inflammatory markers in patients with ulcerative colitis[J]. Phytother Res, 2020, 34(5):1123-1133.
13 WANG H Y, GE W, LIU S Q, et al. Curcumin inhibits T follicular helper cell differentiation in mice with dextran sulfate sodium (DSS)-induced colitis[J]. Am J Chin Med, 2022, 50(1): 275-293.
14 PARAMSOTHY S, NIELSEN S, KAMM M A,et al. Specific bacteria and metabolites associated with response to fecal microbiota transplantation in patients with ulcerative colitis[J].Gastroenterology,2019,156(5): 1440-1454.e2.
15 ZHANG L C, MA X F, LIU P, et al. Treatment and mechanism of fecal microbiota transplantation in mice with experimentally induced ulcerative colitis[J]. Exp Biol Med, 2021, 246(13): 1563-1575.
16 WANG S Y, GUO C, ZHANG T, et al. Tiaochang Xiaoyan extract tablets ameliorate chronic inflammation by activating macrophage lysosomes in chronic colitis rats[J]. Ann Palliat Med, 2021, 10(2): 2203-2216.
17 XU Y Y, FENG H Y, ZHANG Z Y, et al. The protective role of Scorias spongiosa polysaccharide-based microcapsules on intestinal barrier integrity in DSS-induced colitis in mice[J]. Foods, 2023, 12(3): 669.
18 JIANG M R, ZHONG G J, ZHU Y C, et al. Retardant effect of dihydroartemisinin on ulcerative colitis in a JAK2/STAT3-dependent manner[J]. Acta Biochim Biophys Sin, 2021, 53(9): 1113-1123.
19 HUANG C L, HUANG Z H, DING L, et al. Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis[J]. J Transl Med, 2022, 20(1): 354.
20 ZHU L, XU L Z, ZHAO S, et al. Protective effect of baicalin on the regulation of Treg/Th17 balance, gut microbiota and short-chain fatty acids in rats with ulcerative colitis[J]. Appl Microbiol Biotechnol, 2020, 104(12): 5449-5460.
21 WANG J, ZHANG C L, GUO C M, et al. Chitosan ameliorates DSS-induced ulcerative colitis mice by enhancing intestinal barrier function and improving microflora[J]. Int J Mol Sci, 2019, 20(22): 5751.
22 REN M T, GU M L, ZHOU X X, et al. Sirtuin 1 alleviates endoplasmic reticulum stress-mediated apoptosis of intestinal epithelial cells in ulcerative colitis[J]. World J Gastroenterol, 2019, 25(38): 5800-5813.
23 KIM K Y, SON J D, HWANG S J, et al. Fermented glutinous rice extract mitigates DSS-induced ulcerative colitis by alleviating intestinal barrier function and improving gut microbiota and inflammation[J]. Antioxidants, 2023, 12(2): 336.

Comments

PDF(763 KB)

Accesses

Citation

Detail

Sections
Recommended

/